B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ARSA

MOLECULAR TARGET

arylsulfatase A

UniProt: BAH11167NCBI Gene: 4102 compounds

ARSA (arylsulfatase A) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ARSA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1piceatannol0.691
2pirenperone0.691

About ARSA as a Drug Target

ARSA (arylsulfatase A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ARSA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ARSA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.